Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). ResMed's share price for the quarter that ended in Mar. 2025 was $223.85. ResMed's Shares Outstanding (EOP) for the quarter that ended in Mar. 2025 was 147 Mil. Therefore, ResMed's market cap for the quarter that ended in Mar. 2025 was $32,821 Mil.
ResMed's quarterly market cap
declined
from Sep. 2024 ($35,831 Mil) to Dec. 2024 ($33,584 Mil) and
declined
from Dec. 2024 ($33,584 Mil) to Mar. 2025 ($32,821 Mil).
ResMed's annual market cap
increased
from Jun. 2022 ($30,692 Mil) to Jun. 2023 ($32,133 Mil) but then
declined
from Jun. 2023 ($32,133 Mil) to Jun. 2024 ($28,120 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. ResMed's Enterprise Value for Today is $37,505 Mil.
ResMed Market Cap Historical Data
The historical data trend for ResMed's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, ResMed's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
ResMed's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, ResMed's Market Cap distribution charts can be found below:
* The bar in red indicates where ResMed's Market Cap falls into.
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
ResMed's Market Cap for the fiscal year that ended in Jun. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ResMed (NYSE:RMD) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
ResMed Market Cap Related Terms
Thank you for viewing the detailed overview of ResMed's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
RMD has been successfully added to your 